Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis [Phase 2]
Phase 2 clinical trial evaluating a variation of Yupingfeng Powder for allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Causal Associations Between Allergic Rhinitis and Asthma
This clinical trial update reports on potential causal associations between allergic rhinitis and asthma.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: The Relationship Between Allergic Rhinitis, Forward Head Posture, and Anxiety Levels in Iranian Children
This completed clinical trial studied the relationship between allergic rhinitis, forward head posture, and anxiety levels in Iranian childr…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy [Phase 1]
A Phase 1 study of ASP4070 in patients with Cedar Pollinosis has completed, showing safety and immunological response data.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Effect of the Probiotic ES1 and Its Inactivated Form (HT-ES1) Over Symptomatology Asociated With Allergic Rhinitis [NA]
A completed clinical trial evaluated the probiotic ES1 and its inactivated form HT-ES1 for symptoms of allergic rhinitis. It was sponsored b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Efficacy and Safety of Auricular Acupressure in Treating Allergic Rhinitis [NA]
Completed clinical trial evaluating the efficacy and safety of auricular acupressure for allergic rhinitis, including common symptoms such a…
-
FDA approval · 2024-10-24FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Flonase Sensimist Allergy Relief (fluticasone furoate) from Haleon US Holdings LLC.
-
FDA approval · 2024-10-24FDA Approved: CHILDRENS FLONASE ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Children's Flonase Allergy Relief (fluticasone propionate) from Haleon US Holdings LLC.
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT [Phase 2, Phase 3]
A randomized, placebo-controlled Phase 2/3 trial evaluating intralymphatic immunotherapy enhanced by Vitamin D for grass pollen-induced alle…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis [Phase 4]
A Phase 4 clinical trial update reports superior efficacy of Dymista (azelastine hydrochloride and fluticasone propionate nasal spray) in tr…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Development and Evaluation of an Artificial Intelligence Model for the Diagnosis of Aeroallergies
This update covers completed clinical trials evaluating an artificial intelligence model designed to diagnose aeroallergies. The model aims …
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Impact of Carrier Solutions for House Dust Mite Allergen on Allergic Reactions [NA]
A completed clinical trial evaluated carrier solutions for house dust mite allergen and their effect on allergic reactions in allergic rhini…
-
FDA approval · 2024-10-03FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Indoco Remedies Limited)
FDA approved Indoco Remedies Limited's original application for cetirizine hydrochloride, granting approval for a generic antihistamine prod…
-
FDA approval · 2024-09-27FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Montelukast from BluePoint Laboratories under an ANDA, resulting in regulatory approval of t…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Study of Yupingfeng Powder Treating Allergic Rhinitis (AR) [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating Yupingfeng Powder for allergic rhinitis, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction? [NA]
A clinical trial is evaluating whether Batten grafting improves nasal outcomes after septoplasty and turbinate reduction and is currently re…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers [NA]
A completed clinical trial (NCT05122143) evaluated the efficacy and safety of AM-301 for allergic symptoms in perennial allergic rhinitis; r…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation. [NA]
This clinical trial update reports completion of standardisation work for Juniperus oxycedrus and Cupressus arizonica allergen extracts by I…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Graft Reinforcement for Posterior Nasal Nerve Neurectomy in Allergic Rhinitis Surgeries [NA]
The clinical trial NCT05880134 on graft reinforcement for posterior nasal nerve neurectomy in allergic rhinitis surgeries has completed.
-
FDA approval · 2024-09-12FDA Approved: ZYRTEC-D — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for ZYRTEC-D (cetirizine hydrochloride and pseudoephedrine hydrochloride) from Kenvue Brands LLC…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Evaluation of the Benefits of Sublingual AIT (PRACTIS)
Completed clinical trial evaluating the benefits of PRACTIS, a sublingual allergen immunotherapy, for allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis [Phase 3]
This is a Phase 3 clinical trial evaluating the efficacy and safety of CM9241GRU in patients with perennial allergic rhinitis. The study is …
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Exhaled Breath Condensate Biomarkers in CARAS
A clinical trial is ongoing to study exhaled breath condensate biomarkers in individuals with Combined Allergic Rhinitis and Asthma Syndrome…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Allergic Rhinitis With/Without Asthma: Pre- and Post-Qipian Analysis
This ClinicalTrials.gov update notes the completion of a study evaluating allergic rhinitis with/without asthma in relation to Qipian, inclu…
-
FDA approval · 2024-08-15FDA Approved: ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC (cetirizine hydrochloride) filed by Kenvue Brands LLC.